GlassScriptPhysician profile
Alexander Lee Chen
NPI 1457918799
$1,573.42
in general payments reported to CMS, 2019-2025
10 companies · $1,022 in 2025
The $1,022 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $111 · 2023: $50.52 · 2024: $209 · 2025: $1,022.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,282.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $542.83 | 2023-2025 | Signia, Ligasure |
| Kerecis Limited | $176.61 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Polynovo North America LLC | $166.11 | 2025 | Novosorb Btm |
| Aroa Biosurgery Incorporated | $150.04 | 2025 | |
| Lifenet Health | $115.08 | 2025 | Theragenesis Wound Matrix |
| Zimmer Biomet Holdings, INC. | $111.01 | 2020 | |
| Kci USA, INC. | $108.38 | 2019 | |
| Solventum Corporation | $92.51 | 2025 | V.A.C. Veraflo |
| Teleflex LLC | $91.86 | 2019-2025 | Quikclot |
| Rxsight INC | $18.99 | 2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.